Merck & Co., Inc (NYSE: MRK) Continues Its Expansion With Planned Acquisition of Seagen Inc

Merck & Co., Inc (NYSE: MRK) has announced that it is in discussion to purchase Seagen Inc. and may reach an agreement as earlier as this month, according to people familiar with the matter. Merck to offer $200 per share to buy Seagen One of the sources stated that a sale price of around $200 per […]

Merck & Co. Inc (NYSE: MRK) To Move Forward with Plans To Purchase Seagen Inc

According to sources familiar with the matter, Merck & Co. Inc (NYSE: MRK) is moving forward with a possible acquisition of Seagen Inc.. This would be one of the biggest acquisitions of the year. Merck is in discussions to acquire Seagen to expand the cancer medication lineup Last week, The Wall Street Journal reported that […]

$688 Million “ENHANCE” Settlement Could Pull Merck’s Q4, 2012 EPS By 16 Cents

Boston, MA 02/14/2013 (wallstreetpr) – The renowned healthcare solution provider, Merck & Co Inc., (NYSE: MRK) have settled two US investor-lawsuits for $688 million, it declared yesterday. The company was sued by several of its institutional investors (pension funds) in a class action lawsuit over knowingly withholding information about the potential of failure in another […]